Sector
988 stories · page 34 of 50
The company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification and 100% of Super Smart, a Dutch company building a modern adult-use psychedel
Analysts predict that upcoming regulations would impact the current cannabis market in Canada by as much as $2.45 billion annually by 2023
The Canadian company said it will provide training, protocol development, and ongoing support for the clinic, with the “first patient treatments expected at Seattle Ketamine Infusions in early 2022”
With demand for mental health treatments growing in the face of the coronavirus pandemic, the company sees huge potential to address the need for services with new psychedelic therapies combined with an emphasis on technology
It will first provide its accredited medical cannabis continuing education for pharmacists, then implement its Medical Cannabis Management System in Metro Ontario Pharmacies' pharmacy locations across Ontario
NewLight offers a wide range of pain management services including medical, physiotherapy, chiropractic, massage therapy and acupuncture and orthopedic devices and products that support the lifestyles of those living with chronic pain
KGK Science has successfully helped Hofseth Biocare win New Dietary Ingredient status from the US FDA for its CalGo and OmeGo nutritional supplements extracted from Norwegian Atlantic salmon
The Toronto-based company said that Dr. Nanda brings a wealth of experience and leadership to allied health care in North America and India
The protocols for both studies have received Institutional Review Board approval and patient recruitment is expected to occur in early 2022
The products will consist of a range of both THC and CBD dosages in oral formats
Revitalist Chief Executive Officer Kathryn Walker discusses the company’s growth plans and the advantages of its business model
Irwin Naturals also told investors that its shares have become eligible for delivery and depository services with the Depository Trust Company
The UN’s tourism body has said the tourism sector’s recovery would be “fragile” and “slow”, but the pandemic would cost the global tourism sector $US2 trillion in lost revenue in 2021.
Medicinal use is already legal in many European countries
As one of the first psychedelic companies to go public, the firm’s network of ketamine clinics complements its sharp focus on research and development
The integrated healthcare company reported total revenue for the three and nine months ended September 30, 2021, of $2.7 million and $8.2 million respectively
The company’s Virtual Clinics division has the largest medical cannabis telemedicine network in Canada serving over 50,000 patients
Psychedelic companies feel that Compass Pathways results validate efforts to develop next-generation medicine for treating mental health issues
To date, the company said IRP has successfully performed over 10,000 unique treatments for past or present personnel of the Canadian Armed Forces and the Royal Canadian Mounted Police (RCMP), as well as first responders including firefighte
Analysts were impressed with CareRx's 3Q revenue of C$71.3 million, which beat estimates and led to a series of increased price targets
